Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Association between Atopic Dermatitis and the Metabolic Syndrome: A Systematic Review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Th17 Inhibitors in Active Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Swiss (German) Version of the Actinic Keratosis Quality of Life questionnaire

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Melanoma Screening

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  1. Cohort profile: the clinical 'Psoriasis in Adolescents' (PIA) cohort in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Necrotic ulcer on the chin of a previously healthy 38-year-old woman

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: To date, there are no nationwide studies of the social and economic burden of psoriasis to patients in Denmark. Incentives for health care management based on patient-related outcomes and value (IMPROVE) in psoriasis and psoriatic arthritis is a project aimed at assisting movement from activity-based to outcome-based health care management. One of the key objectives in IMPROVE is to describe the disease-associated socioeconomic burden of psoriasis.

METHODS: A case-matched study of the impact of psoriasis on patients' income, employment and health care costs in Denmark was performed. The IMPROVE study was a retrospective analysis of patients with a hospital diagnosis of psoriasis identified from the Danish National Patient Registry (NPR). In total, 13,025 psoriasis patients and 25,629 matched controls were identified from the NPR. Data from psoriasis patients and matched controls were compared for social and economic factors including income, employment, health care costs and risk of comorbidities.

RESULTS: Psoriasis was associated with increased health care costs (mean annual costs +116% compared to control, p < 0.001), peaking in the year of referral to hospital for psoriasis and sustained thereafter. Both direct and indirect costs were significantly higher for patients with psoriasis than controls (p < 0.001). In the years before and immediately following hospital diagnosis, the rates of employment were lower in psoriasis patients than controls. Comorbidities, including cardiovascular (odds ratio 1.93 [95% CI 1.77-2.09]) and psychiatric conditions (odds ratio 2.61 [95% CI 2.30-2.97]), were more prevalent in patients with psoriasis than controls.

CONCLUSION: In Denmark, psoriasis has a significant impact on health care costs, income and employment, and is associated with a range of comorbidities.

OriginalsprogEngelsk
TidsskriftDermatology (Basel, Switzerland)
Vol/bind235
Udgave nummer5
Sider (fra-til)372-379
Antal sider8
ISSN1018-8665
DOI
StatusUdgivet - 2019

Bibliografisk note

© 2019 S. Karger AG, Basel.

ID: 58311772